Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 16, 2009

View Archived Issues

Tenecteplase restores function to occluded central venous catheters

Novel proteasome inhibitor NPI-0052 shows safety in phase I trials

Pharmacyclics presents phase I data on lymphoma agents

Studies find benefit with intravitreal dexamethasone implant in ocular indications

Abbott submits sNDA to FDA for new dosage strengths of Simcor

FDA approves Cequent's IND to initiate phase I clinical trial of CEQ-508 in FAP patients

Salix and FDA hold pre-NDA meeting on rifaximin therapy for non-constipation IBS

Vion receives complete response letter from FDA related to Onrigin NDA

Merck KGaA initiates phase III INSPIRE trial of Stimuvax in advanced NSCLC

Beneficial effects of SUN-11031 in COPD patients with cachexia reported

Novel FLAP inhibitor AM-679 reduces ocular pathology in RSV-infected mice

Takeda claims sGC activators for the treatment of hypertension

InNexus Biotechnology and Xeris to develop subcutaneous delivery of DXL antibodies

Kissei discovers SGLT-1 inhibitors for the treatment of diabetes

Janssen discloses GHS receptor agonists for gastrointestinal disorders

Lilly presents novel BACE inhibitors for Alzheimer's disease

FDA approves Azaya's IND to initiate phase I clinical trial of liposomal docetaxel

Genentech terminates dacetuzumab collaboration with Seattle Genetics

Celsion enrolls first patient in China in phase III trial of ThermoDox in HCC

Bayer Schering withdraws European MAA for Recothrom (thrombin alfa)

Bio-Quant becomes wholly owned subsidiary of NexMed

Elan and Transition Therapeutics modify phase II ELND-005 trial in AD

Welichem begins patient enrollment in phase IIb trial of WBI-1001 creams

Seattle Genetics and Millennium enter into strategic collaboration on SGN-35

Array BioPharma and Amgen partner for small-molecule glucokinase activator program

Polypeptide-doxorubicin conjugate nanoparticles display potent antitumor efficacy in vivo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...